SNDX financials

Syndax Pharmaceuticals (SNDX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

SNDX income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$172.35M–-$273.08M-$285.42M-3.29
2024$23.68M–-$339.67M-$318.76M-3.72
2023$0.00–-$229.95M-$209.36M-2.98
2022$0.00–-$151.76M-$149.34M-2.46
2021$139.71M–$26.22M$24.93M0.46
2020$1.52M–-$71.42M-$77.06M-1.87